AI-driven demand for silicon photonics infrastructure put IQE at the centre of Monday's small-cap technology news, as the compound semiconductor specialist signed a multi-year supply agreement with Tower Semiconductor and settled longstanding IP litigation in a single stroke. Alongside that headline, contract wins for Seeing Machines in Japan and Beeks Financial Cloud in North America underlined a broad day of commercial progress across the sector.
IQE secures multi-year InP epiwafer supply deal with Tower Semiconductor
IQE (AIM:IQE) agreed a multi-year supply arrangement for Indium Phosphide epiwafers to Tower Semiconductor, with the material destined for silicon photonics applications in AI data-centre optical interconnects. The agreement also carries a royalty-free licence that resolves prior intellectual property litigation between the two companies, removing a legal overhang at a stroke. The shares surged 20.0% to 55.5p on the news.
Intercede and Swissbit to co-develop post-quantum FIDO2 passkeys
Intercede Group (AIM:IGP) announced a deepened partnership with hardware security specialist Swissbit to co-develop an end-to-end FIDO2 passkey solution capable of incorporating post-quantum cryptography. The two companies plan an initial public demonstration of the technology at the Identiverse conference in Las Vegas, positioning Intercede at the intersection of passwordless authentication and quantum-resilient security. The stock added 5.4% to 118.0p.
Seeing Machines wins two Japanese OEM in-cabin monitoring contracts
Seeing Machines (AIM:SEE) secured contracts to supply driver and occupant monitoring software to two separate Japanese carmakers, expanding its footprint in one of the world's most demanding automotive markets. The company placed an estimated initial lifetime value of approximately US$11 million on the two programmes combined. The shares rose 6.0% to 4.4p.
Beeks lands $3 million North American exchange analytics contract
Beeks Financial Cloud Group (AIM:BKS) won a $3 million, five-year contract to deploy its Beeks Analytics and Market Edge Intelligence® platform at a North American exchange in New York. The deal pushed the company's total contract wins for June to approximately $10 million in total contract value, a meaningful acceleration in its exchange and clearing segment. Beeks shares climbed 4.0% to 208.0p.
Fusion Antibodies receives InnovateUK grant for DR5 humanisation programme
Fusion Antibodies (AIM:FAB) was awarded an InnovateUK Launchpad grant, in collaboration with Queen's University Belfast, to fund the humanisation of a DR5 therapeutic antibody, a target with relevance in oncology. UKRI extended the project timeline to 31 December, providing additional runway for the development work. The shares edged 2.4% higher to 12.29p.
Team Internet confirms FY25 in line with or above analyst forecasts
Team Internet Group (AIM:TIG) said its full-year 2025 results came in at least in line with analyst expectations, and that trading in 2026 is also tracking in line with forecasts. The update offered no negative surprises and provided reassurance on the group's near-term trajectory. The shares ticked up 1.3% to 40.0p.
